文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

血氨对脓毒症患者病情严重程度及预后的预测价值:一项前瞻性观察研究

[Value of blood ammonia on predicting the severity and prognosis of patients with sepsis: a prospective observation study].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2020-01-01
一句话结论脓毒症患者诊断后6-8小时动脉血氨>36.50 μmol/L预测28天死亡敏感性92.9%、特异性73.9%,可辅助评估病情严重程度与预后。

脓毒性休克组血氨(52.93±34.11 μmol/L)显著高于脓毒症组(29.38±10.37 μmol/L),死亡组血氨(69.98±41.14 μmol/L)显著高于存活组(32.17±11.31 μmol/L)。血氨与APACHE II评分呈正相关(r=0.592)。血氨预测28天死亡的AUC为0.901,以>36.50 μmol/L为界值,敏感性92.9%、特异性73.9%;血氨>36.50 μmol/L者28天累积生存率显著更低。

要点

  • 脓毒症患者诊断后6-8小时动脉血氨>36.50 μmol/L预测28天死亡:敏感性92.9%、特异性73.9%,阳性似然比3.56、阴性似然比0.10。
  • 血氨预测28天死亡的AUC为0.901,与APACHE II评分(AUC 0.846)无统计学差异(P=0.187);APACHE II联合血氨AUC 0.913,显著高于APACHE II单独(P=0.002),但不高于血氨单独(P=0.647)。
  • 脓毒性休克组血氨显著高于脓毒症组(52.93±34.11 vs. 29.38±10.37 μmol/L,P<0.05),死亡组显著高于存活组(69.98±41.14 vs. 32.17±11.31 μmol/L,P<0.05)。
  • 血氨>36.50 μmol/L者28天累积生存率显著低于≤36.50 μmol/L者(Log-Rank χ2=9.620,P=0.002)。
  • 血氨与APACHE II评分呈正相关(r=0.592,P<0.01),与白细胞计数呈中度正相关(r=0.343,P<0.01)。

适用人群与场景

  • 原文未提及明确的纳入标准与排除标准细节(仅提及排除12例不符合纳入标准及失访者)。

诊断标准与关键阈值

  • 脓毒症诊断后6-8小时检测动脉血氨,以>36.50 μmol/L作为预测28天死亡的界值(敏感性92.9%、特异性73.9%)。
  • 按病情严重程度分为脓毒症组与脓毒性休克组;按28天住院结局分为存活组与死亡组。
  • APACHE II评分用于评估病情严重程度,原文未给出具体阈值。

处置流程与药物剂量

  • 原文未提及基于血氨的具体治疗干预或药物剂量方案。

红旗征与不能漏的情况

  • 脓毒症患者动脉血氨>36.50 μmol/L提示28天死亡风险高(敏感性92.9%、特异性73.9%),28天累积生存率显著更低(Log-Rank χ2=9.620,P=0.002)。
  • 脓毒性休克患者血氨显著高于脓毒症患者(52.93±34.11 vs. 29.38±10.37 μmol/L,P<0.05),死亡组血氨显著高于存活组(69.98±41.14 vs. 32.17±11.31 μmol/L,P<0.05)。

研究设计与关键结果

  • 与对照组相比,脓毒症患者血氨、白细胞计数、中性粒细胞比例显著升高[血氨(μmol/L):42.28±28.64 vs. 12.05±5.44,WBC(×10^9/L):17.51±5.13 vs. 6.57±2.20,Neut%:0.87(0.82,0.90)vs. 0.62(0.59,0.67),均P<0.05]。
  • 脓毒性休克组与脓毒症组比较:APACHE II评分(24.49±6.22 vs. 14.31±3.32)、血氨(52.93±34.11 vs. 29.38±10.37 μmol/L)、WBC(20.21±3.77 vs. 14.02±4.23 ×10^9/L)、Neut%[0.89(0.86,0.92)vs. 0.82(0.79,0.89)]及28天死亡率[43.0%(37/86)vs. 7.0%(5/71)]均显著升高(均P<0.05
  • 死亡组与存活组比较:APACHE II评分(26.89±7.91 vs. 17.34±4.90)、血氨(69.98±41.14 vs. 32.17±11.31 μmol/L)、WBC(20.20±4.78 vs. 16.53±4.91 ×10^9/L)、Neut%[0.89(0.87,0.95)vs. 0.87(0.82,0.90)]均显著升高(均P<0.05)。
  • ROC曲线:APACHE II评分与血氨预测28天死亡的AUC分别为0.846和0.901,两者无统计学差异(P=0.187);APACHE II联合血氨的AUC为0.913,显著高于APACHE II单独(P=0.002),但不高于血氨单独(P=0.647)。
  • 血氨界值>36.50 μmol/L预测28天死亡:敏感性92.9%、特异性73.9%,阳性似然比3.56、阴性似然比0.10。
  • Kaplan-Meier生存曲线:血氨>36.50 μmol/L者28天累积生存率显著低于≤36.50 μmol/L者(Log-Rank χ2=9.620,P=0.002)。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究(单中心)。
  • 局限:单中心、样本量较小(最终分析157例)、观察性设计;原文未提及盲法或混杂因素调整;原文结论为血氨可在一定程度上提示脓毒症严重程度与预后。

对床旁实践的改变

  • 对ICU脓毒症患者,可在诊断后6-8小时检测动脉血氨,血氨>36.50 μmol/L提示28天死亡风险高,可辅助病情严重程度评估与预后分层。
  • 血氨单独预测28天死亡的AUC(0.901)与APACHE II评分(0.846)无统计学差异,联合APACHE II并未优于血氨单独(P=0.647),不应将联合检测视为优于血氨单独的策略。
  • 原文未提及基于血氨阈值启动或调整具体治疗的措施,血氨升高不应直接推导为特定治疗干预的指征。
  • 适用人群为ICU脓毒症患者;原文未提及儿科、产科或其他特殊人群,不适用于这些人群的推断。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the value of arterial blood ammonia on predicting the severity and prognosis of patients with sepsis.

METHODS: A prospective observation study was conducted. A total of 169 patients with sepsis admitted to intensive care unit (ICU) of Jining First People's Hospital Affiliated to Jining Medical University from January 2018 to June 2019 were enrolled. Thirty-five healthy volunteers were served as controls. Demographics, acute physiology and chronic health evaluation II (APACHE II) score were recorded. At 6-8 hours after the diagnosis of sepsis, the serum levels of arteria blood ammonia and whole blood cell count were run. The septic patients were divided into the sepsis group and septic shock group according to the disease severity, and the septic patients were divided into survival group and death group according to the outcomes during 28-day hospitalization. The clinical data were compared. Spearman rank correlation was applied to determine the correlation between those variables. The predictive value of the parameters on 28-day mortality was evaluated with receiver operating characteristic (ROC) curve. Kaplan-Meier survival curve analysis was used to compare different blood ammonia levels of patients with 28-day cumulative survival rate.

RESULTS: Among the 169 sepsis patients, after excluding 12 patients who did not meet the inclusion criteria and loss to follow-up, there were finally 157 patients enrolled in the analysis. Among the 157 septic patients, 71 of them were in the sepsis group, and 86 in the septic shock group. After 28-day follow-up, 115 patients survived and 42 died. No significant differences were found in age and gender among groups with different severity and clinical prognosis. Compared with the control group, the blood ammonia, counts of white blood cell (WBC) and neutrophils ratio (Neut%) in serum of sepsis patients were significantly higher [blood ammonia (μmol/L): 42.28±28.64 vs. 12.05±5.44, WBC (×109/L): 17.51±5.13 vs. 6.57±2.20, Neut%: 0.87 (0.82, 0.90) vs. 0.62 (0.59, 0.67), all P < 0.05]. Compared with the sepsis group, the APACHE II score, blood ammonia, WBC, Neut% and 28-day mortality in the septic shock group were significantly higher [APACHE II score: 24.49±6.22 vs. 14.31±3.32,blood ammonia (μmol/L): 52.93±34.11 vs. 29.38±10.37, WBC (×109/L): 20.21±3.77 vs. 14.02±4.23, Neut%: 0.89 (0.86, 0.92) vs. 0.82 (0.79, 0.89), 28-day mortality: 43.0% (37/86) vs 7.0% (5/71), all P < 0.05]. APACHE II score, blood ammonia, WBC and Neut% in the death group were significantly higher than those in the survival group [APACHE II score: 26.89±7.91 vs. 17.34±4.90, blood ammonia (μmol/L): 69.98±41.14 vs. 32.17±11.31, WBC (×109/L): 20.20±4.78 vs. 16.53±4.91, Neut%: 0.89 (0.87, 0.95) vs. 0.87 (0.82, 0.90), all P < 0.05]. Spearman rank correlation analysis showed that blood ammonia in patients with sepsis was correlated well with APACHE II score (r = 0.592, P < 0.01), and there was moderately positive correlation between blood ammonia and the counts of WBC (r = 0.343, P < 0.01). ROC curve analysis showed that the areas under ROC curve (AUC) of APACHE II score and blood ammonia for predicting 28-day mortality were 0.846 and 0.901, respectively, and there was no statistical significance (P = 0.187). The AUC of APACHE II score combined with blood ammonia was significantly higher than that of APACHE II score alone (0.913 vs. 0.846, P = 0.002), but was not higher than that of blood ammonia alone (0.913 vs. 0.901, P = 0.647). Using a blood ammonia cut-off value of > 36.50 μmol/L for predicting 28-day mortality, the sensitivity and specificity was 92.9% and 73.9%, respectively, and the positive and negative likelihood ratios were 3.56 and 0.10, respectively. Kaplan-Meier survival curve analysis indicated that the patients whose blood ammonia was higher than 36.50 μmol/L, had lower 28-day cumulative survival rate when compared with those patients with blood ammonia ≤ 36.50 μmol/L (Log-Rank test: χ2 = 9.620, P = 0.002).

CONCLUSIONS: The level of arterial blood ammonia could somehow indicate the severity and prognosis of sepsis, which could provide evidence for the treatment.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Gao C, Wang D, Li W, et al. [Value of blood ammonia on predicting the severity and prognosis of patients with sepsis: a prospective observation study]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 33463489. doi:10.3760/cma.j.cn121430-20200305-00210

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。